Integra Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Stock Up

Integra LifeSciences Holdings Corporation (IART) delivered adjusted earnings per share (EPS) of 97 cents for the fourth quarter of 2024, which surpassed the Zacks Consensus Estimate by 14.1%. The metric increased 9% year over year.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.The adjustment excludes the impact of certain non-recurring charges like structural optimization charges, divestiture, acquisition and integration-related charges, and EU Medical Device Regulation charges, amon ...